A cross-sectional single-centre study on the spectrum of Pompe disease, German patients: molecular analysis of the GAA gene, manifestation and genotype-phenotype correlations

Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficiency, acid maltase deficiency, OMIM # 232300) is an autosomal-recessive lysosomal storage disorder due to a deficiency of acid alpha-glucosidase (GAA, acid maltase, EC 3.2.1.20, Swiss-Prot P10253). Clinical manifes...

Full description

Saved in:
Bibliographic Details
Main Authors: Herzog, Andreas (Author) , Runz, Heiko (Author)
Format: Article (Journal)
Language:English
Published: 7 June 2012
In: Orphanet journal of rare diseases
Year: 2012, Volume: 7
ISSN:1750-1172
DOI:10.1186/1750-1172-7-35
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1750-1172-7-35
Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1750-1172-7-35
Get full text
Author Notes:Andreas Herzog, Ralf Hartung, Arnold J.J. Reuser, Pia Hermanns, Heiko Runz, Nesrin Karabul, Seyfullah Gökce, Joachim Pohlenz, Christoph Kampmann, Christina Lampe, Michael Beck and Eugen Mengel
Description
Summary:Pompe disease (Glycogen storage disease type II, GSD II, acid alpha-glucosidase deficiency, acid maltase deficiency, OMIM # 232300) is an autosomal-recessive lysosomal storage disorder due to a deficiency of acid alpha-glucosidase (GAA, acid maltase, EC 3.2.1.20, Swiss-Prot P10253). Clinical manifestations are dominated by progressive weakness of skeletal muscle throughout the clinical spectrum. In addition, the classic infantile form is characterised by hypertrophic cardiomyopathy.
Item Description:Gesehen am 12.06.2018
Physical Description:Online Resource
ISSN:1750-1172
DOI:10.1186/1750-1172-7-35